chr19-50293703-C-T
Variant names: 
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001145809.2(MYH14):c.5469+16C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.737 in 1,542,138 control chromosomes in the GnomAD database, including 424,673 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
 Genomes: 𝑓 0.66   (  35484   hom.,  cov: 33) 
 Exomes 𝑓:  0.74   (  389189   hom.  ) 
Consequence
 MYH14
NM_001145809.2 intron
NM_001145809.2 intron
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  -4.41  
Publications
10 publications found 
Genes affected
 MYH14  (HGNC:23212):  (myosin heavy chain 14) This gene encodes a member of the myosin superfamily. The protein represents a conventional non-muscle myosin; it should not be confused with the unconventional myosin-14 (MYO14). Myosins are actin-dependent motor proteins with diverse functions including regulation of cytokinesis, cell motility, and cell polarity. Mutations in this gene result in one form of autosomal dominant hearing impairment. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011] 
MYH14 Gene-Disease associations (from GenCC):
- autosomal dominant nonsyndromic hearing loss 4AInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics
- peripheral neuropathy-myopathy-hoarseness-hearing loss syndromeInheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- nonsyndromic genetic hearing lossInheritance: AD Classification: MODERATE Submitted by: ClinGen
- autosomal dominant nonsyndromic hearing lossInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86). 
BP6
Variant 19-50293703-C-T is Benign according to our data. Variant chr19-50293703-C-T is described in ClinVar as Benign. ClinVar VariationId is 257578.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.901  is higher than 0.05. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| MYH14 | NM_001145809.2 | c.5469+16C>T | intron_variant | Intron 39 of 42 | ENST00000642316.2 | NP_001139281.1 | ||
| MYH14 | NM_001077186.2 | c.5370+16C>T | intron_variant | Intron 38 of 41 | NP_001070654.1 | |||
| MYH14 | NM_024729.4 | c.5346+16C>T | intron_variant | Intron 37 of 40 | NP_079005.3 | 
Ensembl
Frequencies
GnomAD3 genomes  0.661  AC: 100501AN: 152014Hom.:  35464  Cov.: 33 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
100501
AN: 
152014
Hom.: 
Cov.: 
33
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.754  AC: 149415AN: 198216 AF XY:  0.757   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
149415
AN: 
198216
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.745  AC: 1035465AN: 1390006Hom.:  389189  Cov.: 41 AF XY:  0.746  AC XY: 509743AN XY: 683016 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
1035465
AN: 
1390006
Hom.: 
Cov.: 
41
 AF XY: 
AC XY: 
509743
AN XY: 
683016
show subpopulations 
African (AFR) 
 AF: 
AC: 
12159
AN: 
31626
American (AMR) 
 AF: 
AC: 
29639
AN: 
35030
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
15314
AN: 
21474
East Asian (EAS) 
 AF: 
AC: 
35425
AN: 
38948
South Asian (SAS) 
 AF: 
AC: 
58582
AN: 
74664
European-Finnish (FIN) 
 AF: 
AC: 
38954
AN: 
50878
Middle Eastern (MID) 
 AF: 
AC: 
3909
AN: 
5348
European-Non Finnish (NFE) 
 AF: 
AC: 
799947
AN: 
1074786
Other (OTH) 
 AF: 
AC: 
41536
AN: 
57252
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.460 
Heterozygous variant carriers
 0 
 12546 
 25092 
 37637 
 50183 
 62729 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 20046 
 40092 
 60138 
 80184 
 100230 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.661  AC: 100560AN: 152132Hom.:  35484  Cov.: 33 AF XY:  0.669  AC XY: 49765AN XY: 74368 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
100560
AN: 
152132
Hom.: 
Cov.: 
33
 AF XY: 
AC XY: 
49765
AN XY: 
74368
show subpopulations 
African (AFR) 
 AF: 
AC: 
16345
AN: 
41468
American (AMR) 
 AF: 
AC: 
11827
AN: 
15288
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
2507
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
4782
AN: 
5182
South Asian (SAS) 
 AF: 
AC: 
3760
AN: 
4824
European-Finnish (FIN) 
 AF: 
AC: 
8085
AN: 
10584
Middle Eastern (MID) 
 AF: 
AC: 
211
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
51004
AN: 
68000
Other (OTH) 
 AF: 
AC: 
1451
AN: 
2110
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.503 
Heterozygous variant carriers
 0 
 1572 
 3145 
 4717 
 6290 
 7862 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 790 
 1580 
 2370 
 3160 
 3950 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
2912
AN: 
3478
ClinVar
Significance: Benign 
Submissions summary: Benign:8 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not specified    Benign:3 
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
not provided    Benign:3 
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 22, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Autosomal dominant nonsyndromic hearing loss 4A    Benign:1 
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Peripheral neuropathy-myopathy-hoarseness-hearing loss syndrome    Benign:1 
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.